Drug Delivery Business News, reports today that the FDA’s 510(k) database indicates that Tandem recently received clearance for an extended-wear infusion set.

Tandem’s Capillary Biomedical (CapBio) subsidiary develops the SteadiSet Infusion Set. The wearable infusion set delivers insulin from an insulin pump to the body. Tandem — one of the largest diabetes tech companies in the world — develops the t:slim X2 and Mobi insulin pump systems to work with the infusion set.